These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24469434)

  • 1. Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads.
    Burri H; Combescure C
    Europace; 2014 Aug; 16(8):1210-7. PubMed ID: 24469434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death.
    Zhu DWX; Chu MM; House CM
    Europace; 2017 Dec; 19(12):2007-2014. PubMed ID: 27940933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure.
    Da Costa A; Da Cruz C; Romeyer-Bouchard C; Abdellaoui L; Nadrouss A; Bisch L; Chometon F; Afif Z; Gate-Martinet A; Combier M; Isaaz K
    Arch Cardiovasc Dis; 2012 Apr; 105(4):203-10. PubMed ID: 22633294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Caliber Lead Failure After Generator Exchange.
    Salgado R; Martín J; Martínez J; Alzueta J; Viñolas X; Fernández J; Molina M; Pérez L; Calvo D; García J
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):846-50. PubMed ID: 27090984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of a proactive management strategy for the Sprint Fidelis recall: a probabilistic decision analysis model.
    Bashir J; Cowan S; Raymakers A; Yamashita M; Danter M; Krahn A; Lynd LD
    Heart Rhythm; 2013 Dec; 10(12):1761-7. PubMed ID: 24076445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting Sprint Fidelis lead fracture: Results at 5 years from a French multicentre registry.
    Piot O; Deballon R; Nitu D; Marquié C; da Costa A; Leclercq C; Defaye P; Sadoul N
    Arch Cardiovasc Dis; 2015 Apr; 108(4):220-6. PubMed ID: 25858538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generator exchange is associated with an increased rate of Sprint Fidelis lead failure.
    Lovelock JD; Patel A; Mengistu A; Hoskins M; El-Chami M; Lloyd MS; Leon A; DeLurgio D; Langberg JJ
    Heart Rhythm; 2012 Oct; 9(10):1615-8. PubMed ID: 22683747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of generator replacement on the risk of Fidelis lead fracture.
    Krahn AD; Bashir J; Birnie DH; Brown J; Spencer JH; Leander C; Estes NA
    Heart Rhythm; 2016 Aug; 13(8):1618-23. PubMed ID: 27154229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
    Hauser RG; Hayes DL
    Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes in patients with abandoned versus extracted implantable cardioverter defibrillator leads.
    Amelot M; Foucault A; Scanu P; Gomes S; Champ-Rigot L; Pellissier A; Milliez P
    Arch Cardiovasc Dis; 2011 Nov; 104(11):572-7. PubMed ID: 22117909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and long-term outcomes associated with recalled implantable cardioverter-defibrillator leads: A multicenter experience.
    Mar PL; John A; Kumar S; Barry N; Chen G; Longserre S; Kabra R; Atkins D; Koerber S; Hussein A; Bhakta D; Lakkireddy D; Gopinathannair R
    Heart Rhythm; 2020 Nov; 17(11):1909-1916. PubMed ID: 32512178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes.
    Vollmann D; Woronowicz S; Kmiec L; Jung K; Zenker D; Seegers J; Sossalla S; Dorenkamp M; Sohns C; Lüthje L; Hasenfuss G; Zabel M
    Europace; 2014 Feb; 16(2):258-64. PubMed ID: 23813451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.
    Nichols CI; Vose JG; Mittal S
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique.
    Migliore F; Mattesi G; De Franceschi P; Allocca G; Crosato M; Calzolari V; Fantinel M; Ortis B; Facchin D; Daleffe E; Fabris T; Marras E; De Lazzari M; Zanon F; Marcantoni L; Siciliano M; Corrado D; Iliceto S; Bertaglia E; Zecchin M
    J Cardiovasc Electrophysiol; 2019 Jun; 30(6):854-864. PubMed ID: 30827041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis.
    Pokorney SD; Zhou K; Matchar DB; Love S; Zeitler EP; Lewis R; Piccini JP
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):184-91. PubMed ID: 25311559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.